Restylane + Lidocaine and Restylane Lyft for the Treatment of Nasolabial Folds

PHASE3CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

November 13, 2019

Primary Completion Date

December 12, 2019

Study Completion Date

February 12, 2020

Conditions
Wrinkles Such as Nasolabial Folds
Interventions
DEVICE

Restylane + Lidocaine

Restylane + Lidocaine is a HA gel generated by Streptococcus species of bacteria, chemically crosslinked with BDDE, stabilized and suspended in phosphate buffered saline at pH=7 and concentration of 20 mg/mL with 0.3% lidocaine. It is indicated for mid-to-deep dermal implantation for the correction of moderate to severe facial wrinkles and folds, such as NLFs.

DEVICE

Restylane® Lyft

Restylane® Lyft is a sterile gel of HA with lidocaine generated by Streptococcus species of bacteria, chemically cross-linked with BDDE (the cross linker), stabilized and suspended in phosphate buffered saline at pH=7 and concentration of 20 mg/mL. Lyft is intended to be used for facial tissue augmentation (Galderma Laboratories, 2014).

Trial Locations (1)

H3R 3A1

Erevna Innovations Inc, Montreal

Sponsors
All Listed Sponsors
lead

Erevna Innovations Inc.

OTHER